1. Home
  2. ALMS vs BMRC Comparison

ALMS vs BMRC Comparison

Compare ALMS & BMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • BMRC
  • Stock Information
  • Founded
  • ALMS 2021
  • BMRC 1989
  • Country
  • ALMS United States
  • BMRC United States
  • Employees
  • ALMS N/A
  • BMRC N/A
  • Industry
  • ALMS
  • BMRC Major Banks
  • Sector
  • ALMS
  • BMRC Finance
  • Exchange
  • ALMS NYSE
  • BMRC Nasdaq
  • Market Cap
  • ALMS 402.6M
  • BMRC 416.8M
  • IPO Year
  • ALMS 2024
  • BMRC N/A
  • Fundamental
  • Price
  • ALMS $4.13
  • BMRC $22.22
  • Analyst Decision
  • ALMS Strong Buy
  • BMRC Buy
  • Analyst Count
  • ALMS 6
  • BMRC 4
  • Target Price
  • ALMS $19.80
  • BMRC $26.25
  • AVG Volume (30 Days)
  • ALMS 686.1K
  • BMRC 99.1K
  • Earning Date
  • ALMS 08-12-2025
  • BMRC 07-28-2025
  • Dividend Yield
  • ALMS N/A
  • BMRC 4.50%
  • EPS Growth
  • ALMS N/A
  • BMRC N/A
  • EPS
  • ALMS N/A
  • BMRC 0.43
  • Revenue
  • ALMS $17,389,000.00
  • BMRC $93,409,000.00
  • Revenue This Year
  • ALMS N/A
  • BMRC $61.05
  • Revenue Next Year
  • ALMS N/A
  • BMRC $10.99
  • P/E Ratio
  • ALMS N/A
  • BMRC $51.40
  • Revenue Growth
  • ALMS N/A
  • BMRC 59.35
  • 52 Week Low
  • ALMS $2.76
  • BMRC $16.97
  • 52 Week High
  • ALMS $13.11
  • BMRC $27.11
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • BMRC 31.70
  • Support Level
  • ALMS N/A
  • BMRC $23.00
  • Resistance Level
  • ALMS N/A
  • BMRC $23.75
  • Average True Range (ATR)
  • ALMS 0.00
  • BMRC 0.83
  • MACD
  • ALMS 0.00
  • BMRC -0.41
  • Stochastic Oscillator
  • ALMS 0.00
  • BMRC 6.51

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About BMRC Bank of Marin Bancorp

Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties and others. The majority of its revenue comes from interest income.

Share on Social Networks: